CAL
DGX icon

Capital Analysts LLC’s Quest Diagnostics DGX Stock Holding History

Capital Analysts LLC’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$1K – 1552
2026
Q1 		$1K Buy
+4
New +$777 ﹤0.01% 1492
2021
Q3 		– Sell
-10
Closed -$1K – 993
2021
Q2 		$1K Hold
10
– – ﹤0.01% 904
2021
Q1 		$1K Hold
10
– – ﹤0.01% 1005
2020
Q4 		$1K Buy
+10
New +$1.22K ﹤0.01% 715

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Capital Analysts LLC's DGX Position: Q2 2026 in Review

Capital Analysts LLC sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 4 shares — an estimated $1K sold.

Capital Analysts LLC first reported a position in DGX in Q4 2020 and held it in 4 quarters. The position peaked at $1K in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Capital Analysts LLC reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Capital Analysts LLC sold 4 Quest Diagnostics shares in Q2 2026, an estimated $1K.
  • Capital Analysts LLC first reported a position in Quest Diagnostics in Q4 2020 and held it in 4 quarters.
  • Capital Analysts LLC's Quest Diagnostics position peaked at $1K in Q1 2026.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.